Your shopping cart is currently empty

EPI-589, a quinone derivative and oxidoreductase enzyme inhibitor, is considered safe and well tolerated, showing promise for the treatment of amyotrophic lateral sclerosis (ALS).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $46 | 5 days | 5 days |
| Description | EPI-589, a quinone derivative and oxidoreductase enzyme inhibitor, is considered safe and well tolerated, showing promise for the treatment of amyotrophic lateral sclerosis (ALS). |
| Targets&IC50 | Oxidoreductase enzyme: |
| In vivo | EPI-589 significantly enhances biomarkers in cerebrospinal fluid (CSF) and plasma associated with neuroinflammation and ALS disease progression. |
| Molecular Weight | 265.31 |
| Formula | C14H19NO4 |
| Cas No. | 1147883-03-1 |
| Smiles | C(C[C@@](C(N)=O)(C)O)C1=C(C)C(=O)C(C)=C(C)C1=O |
| Relative Density. | 1.187 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.